Chemours (CC)
(Delayed Data from NYSE)
$16.13 USD
-0.21 (-1.29%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $16.13 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CC 16.13 -0.21(-1.29%)
Will CC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CC
Can UUUU's Rare Earths Revolutionize EV Magnet Supply Chains?
Can UUUU and Vulcan Elements Strengthen U.S. Rare Earth Magnet Supply?
CC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chemours Enters Strategic Agreement With SRF to Boost Supply
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes
Chemours (CC) Reports Q2 Earnings: What Key Metrics Have to Say
Other News for CC
CC forms 20 Day Moving Average Resistance on October 3
CC Crossed Above 20 Day Moving Average on October 3
CC forms Bollinger Band Squeeze on October 1
Stochastic Buy Signal appears for CC after 1.54% move
Core Silver Extends High-Grade Silver-Polymetallic Sulphide Mineralization at the Jackie Target